EBookClubs

Read Books & Download eBooks Full Online

EBookClubs

Read Books & Download eBooks Full Online

Book Prognostic and Predictive Factors in Gynecologic Cancers

Download or read book Prognostic and Predictive Factors in Gynecologic Cancers written by Charles F. Levenback and published by CRC Press. This book was released on 2007-09-15 with total page 348 pages. Available in PDF, EPUB and Kindle. Book excerpt: Gynecologic oncology takes a fresh look at a critical aspect of cancer treatment planning. An international team of authors reviews the traditional prognostic and predictive factors such as tumor grade, histologic subtype, and grade and then goes a step further to review the growing number of molecular discoveries that have increasing clinical significance. The book is organized into comprehensive sections on ovarian, endometrial and cervical cancer and includes up to date reviews, newly discovered molecular pathways, genetic markers, molecular imaging techniques, and their relevance to clinical medicine. Prognostic and Predictive Factors in Gynecologic Oncology is illustrated with over 100 figures and is essential reading for oncologists, translational and basic scientists, as well as fellows, residents and students with a special interest in gynecologic oncology.

Book Prognostic and Predictive Factors in Breast Cancer

Download or read book Prognostic and Predictive Factors in Breast Cancer written by Rosemary A. Walker and published by CRC Press. This book was released on 2008-09-04 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This title reviews the key prognostic factors in breast cancer, discussing the methodologies involved in measuring and reporting. It also examines the roles of major predictive markers such as the steroid receptors, p53 and HER-2. Given the wealth of information in the medical literature on breast cancer, this volume is useful in that it focuses strictly on these factors. That focus makes this text extremely useful for oncologists and researchers who want to learn more about best practices in prognoses.

Book Prognostic and Predictive Factors in Breast Cancer  Second Edition

Download or read book Prognostic and Predictive Factors in Breast Cancer Second Edition written by Rosemary A. Walker and published by CRC Press. This book was released on 2003-06-12 with total page 232 pages. Available in PDF, EPUB and Kindle. Book excerpt: This title reviews the key prognostic factors in breast cancer, discussing the methodologies involved in measuring and reporting. It also examines the roles of major predictive markers such as the steroid receptors, p53 and HER-2. Given the wealth of information in the medical literature on breast cancer, this volume is useful in that it focuses strictly on these factors. That focus makes this text extremely useful for oncologists and researchers who want to learn more about best practices in prognoses.

Book Uterine Cancer

    Book Details:
  • Author : Franco Muggia
  • Publisher : Springer Science & Business Media
  • Release : 2009-06-10
  • ISBN : 1603270442
  • Pages : 302 pages

Download or read book Uterine Cancer written by Franco Muggia and published by Springer Science & Business Media. This book was released on 2009-06-10 with total page 302 pages. Available in PDF, EPUB and Kindle. Book excerpt: For the Editors, the task of writing a Preface is most satisfying. It represents the completion of the book and a moment of reflection on whether the whole is more than the sum of all the parts. And also, one must reflect on how this book is likely to be utilized in this era of rapid communications. The Editors first met in May 2003 at a stimulating Italian symposium on endometrial cancer (organizers Drs. Luigi Frigerio, Roberto Grassi and Andrea Lissoni, with participation of the deans of Italian Gynecologic Oncology, Ugo Bianchi and Constantino Mangioni) that took place at Bergamo and Caravaggio. The impressive gains in biology and clinical trials were further discussed by the two editors and others that are co-authors in this venture on this side of the Atlantic at a 2004 Educational Session at the American Society of Clinical Oncology (ASCO). The pace of progress in various aspects of management of uterine cancer was no- worthy, not only was tumor biology fueling novel hypotheses such as questioning the mesenchymal origin of carcinosarcomas, but knowledge of molecular pathways was beginning to be applied as prognostic and as predictive factors portending benefit from systemic therapies. Surgical staging and sensitive imaging provided the underpinning for refining our treatment algorithms. Finally, a role for che- therapy had finally become established, principally through phase III studies c- paring chemotherapy to radiation in mostly locally advanced stages III and IV that had undergone resection.

Book Diagnosis and Treatment of Rare Gynecologic Cancers   E Book

Download or read book Diagnosis and Treatment of Rare Gynecologic Cancers E Book written by Michael Frumovitz and published by Elsevier Health Sciences. This book was released on 2022-05-10 with total page 387 pages. Available in PDF, EPUB and Kindle. Book excerpt: Offering a one-stop guide to recognition and therapeutic decision making, Diagnosis and Treatment of Rare Gynecologic Cancers fills a gap in the medical literature on uncommon ovarian, uterine, cervical, and vulvovaginal cancers and trophoblastic diseases. This authoritative text, edited by Drs. Michael Frumovitz, Mario Leitao, and Preetha Ramalingam, has been authored by internationally recognized experts from top institutions such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Each chapter covers different cancer subtypes and has been reviewed by an oncologist and a pathologist. - Provides up-to-date clinical guidance on assessment and therapeutic options for patients with rare gynecologic malignancies. - Presents information in a templated, easy-to-read format. Each chapter includes an introductory clinical case followed by epidemiology of disease, pathologic assessment, basic science/molecular/translational research, work-up of newly diagnosed disease, staging, treatment of newly diagnosed disease, treatment of recurrent disease, potential therapeutic targets, and a case resolution. - Includes diagnostic and treatment algorithms for each form of cancer. - Contains numerous anatomical figures, radiographs, photographs, and tables for quick visual reference.

Book Prognostic and Predictive Factors in Primary Breast Cancer

Download or read book Prognostic and Predictive Factors in Primary Breast Cancer written by Pierre Stefanus Gerardus Johannes Hupperets and published by . This book was released on 1995 with total page 143 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Novel Immune Markers and Predictive Models for Immunotherapy and Prognosis in Breast and Gynecological Cancers

Download or read book Novel Immune Markers and Predictive Models for Immunotherapy and Prognosis in Breast and Gynecological Cancers written by Chao Liu and published by Frontiers Media SA. This book was released on 2024-06-05 with total page 203 pages. Available in PDF, EPUB and Kindle. Book excerpt: Precision medicine is an emerging practice by which clinicians aim to deliver a personalized treatment program to affected patients based on information gained from their individual clinical and biological profiles. In the context of precise cancer immunotherapy, multi-omics, high-throughput sequencing, big data, and other approaches serve to screen new predictive factors for immunotherapy response and prognosis in cancer patients.

Book Noninvasive Molecular Markers in Gynecologic Cancers

Download or read book Noninvasive Molecular Markers in Gynecologic Cancers written by Debmalya Barh and published by CRC Press. This book was released on 2015-01-22 with total page 516 pages. Available in PDF, EPUB and Kindle. Book excerpt: Early detection is critical for any given cancer. With the advent of the latest omics technologies, molecular markers in combination with conventional diagnostic and screening methods are emerging as next-generation early diagnostic and prognostic strategies that can allow early-stage diagnosis, resulting in more effective treatment and patient car

Book Systems Biology of Cancer

Download or read book Systems Biology of Cancer written by Sam Thiagalingam and published by Cambridge University Press. This book was released on 2015-04-09 with total page 597 pages. Available in PDF, EPUB and Kindle. Book excerpt: An overview of the current systems biology-based knowledge and the experimental approaches for deciphering the biological basis of cancer.

Book Prognostic variables in node negative and node positive breast cancer

Download or read book Prognostic variables in node negative and node positive breast cancer written by Giampietro Gasparini and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 416 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Gynecologic Cancers

    Book Details:
  • Author : Kunle Odunsi, MD
  • Publisher : Demos Medical Publishing
  • Release : 2013-10-09
  • ISBN : 1936287897
  • Pages : 315 pages

Download or read book Gynecologic Cancers written by Kunle Odunsi, MD and published by Demos Medical Publishing. This book was released on 2013-10-09 with total page 315 pages. Available in PDF, EPUB and Kindle. Book excerpt: Gynecologic Cancers summarizes issues related to the treatment of gynecologic cancer including descriptions of optimal multidisciplinary care utilizing all available modalities as well as related issues such as screening and prevention, management for special populations, psychological support and emerging directions in future treatment.

Book Gynecologic Cancer

    Book Details:
  • Author : Patricia J. Eifel
  • Publisher : Springer Science & Business Media
  • Release : 2006-04-19
  • ISBN : 0387287965
  • Pages : 327 pages

Download or read book Gynecologic Cancer written by Patricia J. Eifel and published by Springer Science & Business Media. This book was released on 2006-04-19 with total page 327 pages. Available in PDF, EPUB and Kindle. Book excerpt: Gynecologic cancer includes cancer of the female lower genital tract: vagina, vulva, cervix, endometrium, uterus, and ovaries. Gynecologic Cancer is the fourth volume in the M.D. Anderson Cancer Care Series, featuring the current standard approach to gynecologic cancer care from the experts at M.D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include primary prevention and early detection, preinvasive diseases of female lower genital tract, pathology and imaging of gynecologica malignancies, treatment of vaginal, cervical, endometrial, uterine cancers. Discussions also address fertility-sparing options for treatment of women with gynecologica cancers as well as sexuality in women with gyn malignancies. Each of the 20 chapters ends with an up-to-date list of suggested readings, as well as "key practice points" highlighting the most principles and practices of each chapter for at-a-glance reference. More than 80 illustrations complement the text. This thorough, practical volume is the essential clinical guide for the oncologists, surgeons, and all physicians involved in the care of patients with gynecologic cancer.

Book On Prognostic and Treatment Predictive Factors in Early Stage Breast Cancer

Download or read book On Prognostic and Treatment Predictive Factors in Early Stage Breast Cancer written by Ann-Marie Billgren and published by . This book was released on 2002 with total page 40 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Long term Prognostic and Predictive Factors in Hormone Receptor Positive Breast Cancer

Download or read book Long term Prognostic and Predictive Factors in Hormone Receptor Positive Breast Cancer written by Helena Fohlin and published by . This book was released on 2018 with total page 71 pages. Available in PDF, EPUB and Kindle. Book excerpt: The breast cancer survival in Sweden is good (almost 90 % 5-year relative survival) and has increased over time. For women with hormone receptor negative tumors, most relapses occur within the first 5 years after diagnosis. Thereafter the recurrence risk decreases rapidly. For women with estrogen receptor positive (ER+) tumors the annual risk for late recurrences is 1 – 2 %, even after 5 years of endocrine therapy. This risk accumulates so that approximately 25 % of the patients that are recurrence-free after five years from diagnosis may experience a relapse within further 15 years of follow-up. The relatively high long-term risk calls for identification of prognostic and predictive markers with long-term effect. Though, the number of such markers with proven significance is limited. Of the clinical characteristics, only nodal status and to some extent tumor size and tumor grade have been shown to have long-term prognostic value. In this thesis, we propose long-term prognostic and predictive markers for breast cancer. In paper I , we suggest the protein v-akt murine thymoma viral oncogene homologue 2 (AKT2) as a long-term prognostic marker among patients with ER+ tumors. In our study, besides nodal status, AKT2 was the only factor with long-term prognostic value. This is in accordance with some other studies, though we also showed that the significance of AKT2 was limited to ER+ tumors and that the impact increased with higher ER expression. Approximately 75 – 85 % of the ER+ tumors are also progesterone receptor positive (PR+). ER+/progesterone receptor negative (PR-) tumors are considered to be more aggressive and patients with such tumors are often treated with chemotherapy. In this group, more specific subgroups for targeted therapy are needed. Whereas ER has long been established as a predictive factor regarding tamoxifen benefit, the role of PR has not been clarified to date. In paper II , we showed that PR status adds predictive value to ER considering the long-term benefit from tamoxifen. In paper III , we aimed to identify new prognostic markers among patients with ER+ tumors. Systemically untreated patients with ER+/PR- tumors and high expression of the Ras-related protein RAB6C (RAB6C) had reduced distant recurrence rate. Therefore, we suggest RAB6C as a candidate marker for subgroup division among patients with ER+/PR- tumors. According to the results from paper II, there might be subgroups of patients with ER+/PRtumors that do benefit from tamoxifen. The aim of paper IV was to identify such subgroups. Here, we suggest that patients with ER+/PR- tumors and low RAB6C expression do benefit from tamoxifen. The results from this thesis may encourage further studies for more specific subgroup divisions. Such studies may lead to changes in the management program, where some patients with ER+ tumors should receive prolonged or more intense treatment and others reduced treatment based on the pathological markers AKT2, PR and RAB6C.

Book NIH Consensus Statement

Download or read book NIH Consensus Statement written by and published by . This book was released on 2000-11 with total page 44 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Prognostic and Predictive Response Therapy Factors in Cancer Disease  Colorectal  Breast  Liver  Lung  Gastric  Renal and Prostate Cancers

Download or read book Prognostic and Predictive Response Therapy Factors in Cancer Disease Colorectal Breast Liver Lung Gastric Renal and Prostate Cancers written by Vincenzo Canzonieri and published by Nova Science Publishers. This book was released on 2015 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Exploring prognostic and predictive response therapy factors in cancer disease is one of the most exciting issues of modern oncological science. Targeting intracellular signalling molecules is one of the novel approaches in which basic and translational researches meet clinical practice to define the best management of malignancies. The goal for target therapies is to identify agents that target tumor-specific molecules, thus sparing normal tissues. Those molecules are called biomarkers, and their identification is recommended for correct therapeutic planning. Hence, the contribution of clinical and surgical pathology to define cancer prognostic groups and treatment responsive tumors is essential not only for the efficacy of the cures, but also for ethical, economical, and social reasons. The promises of tailored (personalized) therapy are now almost certainly realistic and can give concrete hope to many cancer patients in the world. In this book, we have tried to describe the "state of art" in these fields of oncology, specifically considering prognostic and predictive response therapy factors in colorectal, breast, lung, gastric, renal, liver and prostate cancers.

Book Gynecologic Oncology

Download or read book Gynecologic Oncology written by Robert F. Ozols and published by Springer. This book was released on 1998 with total page 408 pages. Available in PDF, EPUB and Kindle. Book excerpt: Text focusing primarily on ovarian cancer. Explores advances in cytoreductive surgery, problems in screening, new drugs, chemotherapy, hereditary basis for gynecologic malignancies, molecular genetics, molecular biology, and new biologic therapies. For researchers and pathologists, surgeons, chemotherapists, and practitioners.